In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies.

Journal of Biomolecular Structure & Dynamics
Milica RadanKatarina Nikolic

Abstract

A wide range of neuropsychological disorders is caused by serotonin 5-HT2A receptor (5-HT2AR) malfunction. Therefore, this receptor had been frequently used as target in CNS drug research. To design novel potent 5-HT2AR antagonists, we have combined ligand-based and target-based approaches. This study was performed on wide range of structurally diverse antagonists that were divided into three different clusters: clozapine, ziprasidone, and ChEMBL240876 derivatives. By performing the 50 ns long molecular dynamic simulations with each cluster representative in complex with 5-HT2A receptor, we have obtained virtually bioactive conformations of the ligands and three different antagonist-bound, inactive, conformations of the 5-HT2AR. These three 5-HT2AR conformations were further used for docking studies and generation of the bioactive conformations of the data set ligands in each cluster. Subsequently, selected conformers were used for 3D-Quantitative Structure Activity Relationship (3D-QSAR) modelling and pharmacophore analysis. The reliability and predictive power of the created model was assessed using an external test set compounds and showed reasonable external predictability. Statistically significant variables were used to d...Continue Reading

References

Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Feb 23, 2002·Journal of Molecular Graphics & Modelling·Alexander Golbraikh, Alexander Tropsha
Feb 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerard J MarekLawrence H Price
Mar 21, 2003·Nature·Caitlin Smith
Mar 17, 2004·Current Opinion in Pharmacology·Herbert Y Meltzer
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Jan 7, 2006·Bioinformatics·Mikhail A LomizeHenry I Mosberg
Jan 31, 2006·Journal of Affective Disorders·Damiaan DenysHerman G M Westenberg
Feb 23, 2007·Bioorganic & Medicinal Chemistry Letters·Kevin J WilsonAngus M MacLeod
Jul 28, 2007·Neuroscience and Behavioral Physiology·N K PopovaI Z Plyusnina
Dec 28, 2007·Bioorganic & Medicinal Chemistry Letters·James M GrahamSham S Nikam
Aug 13, 2008·Journal of Chemical Information and Modeling·Angel DuránManuel Pastor
Jan 8, 2009·Journal of Chemical Information and Modeling·Oliver KorbThomas E Exner
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Jun 30, 2009·Bioorganic & Medicinal Chemistry Letters·Ian P HolmesAngela Worby
Sep 5, 2009·Journal of Chemical Information and Modeling·Angel DuránManuel Pastor
Aug 3, 2010·Bioorganic & Medicinal Chemistry Letters·Massimo GianottiMark J Wigglesworth
Dec 29, 2011·Journal of Chemical Information and Modeling·Kunal RoyHumayun Kabir
Feb 11, 2012·Methods in Molecular Biology·Irina Kufareva, Ruben Abagyan
Oct 9, 2012·Chemical Biology & Drug Design·Vani MunusamyLip Yong Chung
Oct 23, 2013·European Journal of Clinical Pharmacology·G DésaméricqP Maison
Jan 2, 2014·Pharmacological Reviews·Gregory SliwoskiEdward W Lowe
Jan 20, 2015·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Shih-Hsien LinYen Kuang Yang
Apr 18, 2015·Nucleic Acids Research·Mark DaviesJohn P Overington
Jun 10, 2015·Progress in Molecular Biology and Translational Science·Michèle DarmonJustine Masson
Apr 15, 2016·Nature Protocols·Stefano ForliArthur J Olson
May 9, 2016·British Journal of Pharmacology·C MunkD E Gloriam
Jun 18, 2016·Methods in Molecular Biology·Jayeeta GhoshRobert Fraczkiewicz
Jul 12, 2010·Molecular Informatics·Alexander Tropsha
Jan 28, 2017·Cell·Daniel WackerBryan L Roth
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Feng LinYan Li

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
PCA

Software Mentioned

AutoDock Vina
GOLPE ( Generating
ChEMBL
SPSS
CGENFF
Chem3D
ChemPLP
Gaussian
ALMOND
GOLD

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here